""For all of the projects that we're working on, we want to put the animals back into some form of a native habitat where they can survive, they can be accretive to the ecosystem.""
""The team is in the last stages of editing. The next stage will be doing embryo transfer into elephants.""
Colossal has obtained and mapped bluebuck DNA, entering the final phase of genomic editing. The company plans for a birth around 2028, following a nine-month gestation via a surrogate. The goal is to support re-wilding efforts in collaboration with South African conservation groups. CEO Ben Lamm emphasizes that the de-extinction projects will foster new technologies and biodiversity initiatives. Colossal does not intend to create a zoological endeavor but aims to return revived species to their native habitats for ecological benefits.
Read at Axios
Unable to calculate read time
Collection
[
|
...
]